Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Citius Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 71 | 2 | 77 | +8 |
| Shares | 25.1M | 209.8K | 24.4M | −514.2K (−2.1%) |
| Value | $51.1M | $425.0K | $37.6M | −$13.0M (−25.7%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Allspring Global Investments Holdings, LLC | 521,519 | $803.0K | 0.00% |
| Alberta Investment Management Corp | 172,185 | $265.0K | 0.00% |
| HRT Financial LP | 90,871 | $139.0K | 0.00% |
| Alpine Global Management, LLC | 83,475 | $129.0K | 0.02% |
| Cambridge Investment Research Advisors, Inc. | 54,887 | $85.0K | 0.00% |
| ExodusPoint Capital Management, LP | 50,133 | $77.0K | 0.00% |
| Jane Street Group, LLC | 40,984 | $63.0K | 0.00% |
| Sabby Management, LLC | 30,863 | $48.0K | 0.01% |
| Principal Financial Group Inc | 17,470 | $27.0K | 0.00% |
| Credit Suisse AG | 15,784 | $24.0K | 0.00% |
| Bank of Montreal | 13,449 | $21.0K | 0.00% |
| CoreCap Advisors, LLC | 1,750 | $3.00K | 0.00% |
| Clear Perspectives Financial Planning, LLC | 400 | $1.00K | 0.00% |
| TD Waterhouse Canada Inc. | 70 | $150 | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
| Toronto Dominion Bank | 13 | $0 | 0.00% |
Sold out (8)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Renaissance Technologies LLC | 888,501 | $1.80M |
| Connor, Clark & Lunn Investment Management Ltd. | 172,738 | $351.0K |
| Wealthspire Advisors, LLC | 39,500 | $80.0K |
| AQR Capital Management LLC | 18,243 | $37.0K |
| Cetera Advisor Networks LLC | 15,000 | $30.0K |
| Raymond James & Associates | 11,570 | $23.0K |
| Squarepoint Ops LLC | 10,001 | $20.0K |
| Tradition Wealth Management, LLC | 1,800 | $4.00K |
Not filed for Q4 2021 yet (2)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Wealth Advisory Solutions, LLC | 156,850 | $318.0K |
| Freed Investment Group | 52,900 | $107.0K |